{"id":"https://genegraph.clinicalgenome.org/r/a2ee6217-7316-417a-9118-6986a49acf83v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the ERCC5 gene with xeroderma pigmentosum group G since the gene-disease relationship was first proposed by Nouspikel and Clarkson (1994). Multiple case level studies have been performed with XPG patients that have variants in the ERCC5 gene. 8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway were reported to cause Xeroderma Pigmentosum. Multiple xpg deficient mouse models have been established to show consistent phenotypes with XPG patients, including growth retardation, short life span and highly sensitive to UV light. All of these types of All of these types of evidence are consistent with a definitive relationship between the ERCC5 gene and xeroderma pigmentosum group G.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/a2ee6217-7316-417a-9118-6986a49acf83","GCISnapshot":"https://genegraph.clinicalgenome.org/r/fc08c954-8ded-449b-8f67-e4f044b26cda","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/fc08c954-8ded-449b-8f67-e4f044b26cda_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2019-04-19T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/fc08c954-8ded-449b-8f67-e4f044b26cda_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc08c954-8ded-449b-8f67-e4f044b26cda_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fc08c954-8ded-449b-8f67-e4f044b26cda_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a79291e7-48cb-4e75-a64b-1042f7efcbf3","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c8201e7d-fcf1-4cd5-9393-4dd4dfba401e","type":"Finding","dc:description":"The XpgD811stop homozygous mice exhibited growth retardation and a short life span. Cells from the XpgD811stop and the Xpg\u0003dellex15 homozygotes were highly sensitive to UV light.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15082767","rdfs:label":"Xpg Mutant Mice Generated by cDNA-Mediated Knock-In Method","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4f7fe06f-65b4-4a36-be8d-b33ed9b2e245","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc92b289-e9e9-4f34-9803-2e0c9cd34c2a","type":"Finding","dc:description":"The xpg-deficient mice exhibited postnatal growth failure and underwent premature death. UV sensitivities of xpg-deficient cells and kinetic analysis of UV damage removal indicate that the NER activity is defective in the xpg -/- mice.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10022922","rdfs:label":"Growth failure and UV sensitivities in xpg-deficient mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/fc08c954-8ded-449b-8f67-e4f044b26cda_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/811122d3-0af9-40f4-9056-8f2c49278fe2","type":"EvidenceLine","dc:description":"Eight genes","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b6d8161-359c-4753-8834-231f99e06b79","type":"Finding","dc:description":"8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway cause Xeroderma Pigmentosum.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24105368","rdfs:label":"8 complementation groups genes cause Xeroderma Pigmentosum","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/fc08c954-8ded-449b-8f67-e4f044b26cda_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80ee4459-44a6-4986-b8d2-2d76bfd46a47_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations in the ERCC5 gene. One allele carried a 2573T-C transition, resulting in a leu858-to-pro (L858P) substitution within the evolutionarily conserved I region that is thought to form part of the XPG endonuclease active site (Constantinou et al., 1999). The other allele carried a 4-bp deletion removing AGGA from nucleotide positions 1114 to 1117. The deletion created a frameshift resulting in a truncated protein of 376 amino acids. Mutant L858P proteins have severely diminished endonuclease activity.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc71727d-452e-4993-8c60-44d1916a3bd5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11841555","rdfs:label":"XP2BI","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000992"],"previousTesting":true,"previousTestingDescription":"Cheesbrough, 1978; Keijzer et al., 1979","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/80ee4459-44a6-4986-b8d2-2d76bfd46a47_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11841555","allele":[{"id":"https://genegraph.clinicalgenome.org/r/966023bf-aaae-4bee-9c63-38a0544d715d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.2573T>C (p.Leu858Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16573"}},{"id":"https://genegraph.clinicalgenome.org/r/052c78a5-c5b7-4af7-807a-e70ae09cd3d8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.1115_1118delGGAA (p.Arg372Thrfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16574"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1c83e0b9-eb94-461d-b6e9-1bf3ffb1e073_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations in the ERCC5 gene: a 3075G-T transversion resulting in a glu960-to-ter (Q960X) substitution, and a 2572C-T transition in the ERCC5 gene, resulting in an ala792-to-val (A792V) substitution. In vitro functional expression studies showed that neither mutant protein was able to correct UV sensitivity.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4288a59d-6f13-422f-99d3-6153cf43e5c2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7951246","rdfs:label":"XP125LO","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Restriction digest","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/1c83e0b9-eb94-461d-b6e9-1bf3ffb1e073_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7951246","allele":[{"id":"https://genegraph.clinicalgenome.org/r/783c45b6-cd13-47e9-87a2-08c44b9050da","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.2375C>T (p.Ala792Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16567"}},{"id":"https://genegraph.clinicalgenome.org/r/7eb1fcd3-497b-4874-b940-24f815948d89","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.2878G>T (p.Glu960Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16566"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ff92a1aa-b7b0-4507-b2c8-a15c96ae850f_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A homozygous 1-bp deletion within an AAA triplet at nucleotides 2170-2172, which resulted in a TGA stop codon after amino acid 659. Such a deletion was considered characteristic of a slippage error during DNA replication.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc7fa123-fd78-470a-820c-3a951fabb169","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9096355","rdfs:label":"XPCS1LV","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":6,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001263","obo:HP_0000252","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ff92a1aa-b7b0-4507-b2c8-a15c96ae850f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9096355","allele":{"id":"https://genegraph.clinicalgenome.org/r/dcaefeed-58aa-4530-98fa-21dbfa4404b0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"ERCC5, 1-BP DEL, 2170A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16569"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/95d2914b-9a74-4e79-934e-e5e411337e1a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations in the ERCC5 gene: a 984C-T transition resulting in an arg263-to-ter (R263X) substitution and a 1-bp deletion within an AAA triplet at nucleotides 2170-2172, which resulted in a TGA stop codon after amino acid 659. The 984C-T transition was located within a CpG dinucleotide and thus may have resulted from deamination of a 5-methylcytosine.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80585c0a-ec66-4338-b59f-652fcc95f07d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9096355","rdfs:label":"XPCS2LV","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":20,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000252","obo:HP_0001999","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/95d2914b-9a74-4e79-934e-e5e411337e1a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9096355","allele":[{"id":"https://genegraph.clinicalgenome.org/r/dcaefeed-58aa-4530-98fa-21dbfa4404b0"},{"id":"https://genegraph.clinicalgenome.org/r/00900aca-9adb-4130-ae87-37403ef7ec56","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.787C>T (p.Arg263Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16570"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/88d3e0af-4204-4e5a-a2d6-8f8d4bf82ccb_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 small deletions in the ERCC5 gene. One allele had deletion of an adenosine from a stretch of 4 adenosines at nucleotides 1491 to 1494 resulting frameshift generated a truncated protein of 521 amino acids. And the other had a deletion of an adenosine in a stretch of 9 adenosines at positions 2743 to 2751 of the ERCC5 gene. 917fs962fs XPG proteins have severely diminished endonuclease activity.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a663431-6c1a-41bd-be21-87507652d5d0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11841555","rdfs:label":"XP3BR","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069"],"previousTesting":true,"previousTestingDescription":"Arlett et al. (1980)","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/88d3e0af-4204-4e5a-a2d6-8f8d4bf82ccb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11841555","allele":[{"id":"https://genegraph.clinicalgenome.org/r/2a054846-40a1-4c0c-ae35-3445b1bd46d9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.2751delA (p.Lys917Asnfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16576"}},{"id":"https://genegraph.clinicalgenome.org/r/5716cb10-f566-4676-9cc7-b1a9e25c552e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.1494delA (p.Asp499Ilefs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16575"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f8f1d6e5-7d12-49c8-bbda-0ec5b9c71d51_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations in the ERCC5 gene: a 526C-T transition resulting in a gln176-to-ter (Q176X) substitution, and a 215C-A transversion resulting in a pro72-to-his (P72H) substitution. The P72H substitution was expected to seriously impair the 3-prime endonuclease function of XPG.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a1bfb85-1e35-4f1b-8e9f-fa5f563d5fd5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11228268","rdfs:label":"XPCS4RO","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000519","obo:HP_0012758","obo:HP_0012469","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/f8f1d6e5-7d12-49c8-bbda-0ec5b9c71d51_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11228268","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0b402320-3aa7-4987-aa47-1f60fba7351d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.526C>T (p.Gln176Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16571"}},{"id":"https://genegraph.clinicalgenome.org/r/2468f764-8597-412d-b900-38309455afbe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000123.3(ERCC5):c.215C>A (p.Pro72His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16572"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":455,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/mboJPdmmmnY","type":"GeneValidityProposition","disease":"obo:MONDO_0010216","gene":"hgnc:3437","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_fc08c954-8ded-449b-8f67-e4f044b26cda-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}